12
Participants
Start Date
July 27, 2022
Primary Completion Date
July 27, 2026
Study Completion Date
July 27, 2026
Multispectral Optoacoustic Tomography Imaging
Each participants will undergo MSOT imaging of the suspicious breast tumor detected with ultrasound imaging and any additional lesion present in either breast before undergoing ultrasound-guided breast biopsy as the standard of care. Melanoma participants with pathologically confirmed ITM will undergo MSOT imaging following physical exam and biopsy. Melanoma patients receiving immunotherapy will undergo MSOT imaging prior to and following immunotherapy.
Memorial Sloan - Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only), Commack
Memorial Sloan Kettering Bergen (Consent only ), Montvale
Helmholtz Institute (Data Analysis Only), Munich
Memorial Sloan Kettering Cancer Center
OTHER